Metastasis ability, genomic profile, subtype characteristic and curative efficacy of multiple pulmonary hematogenous metastases in lung cancer

Documenti analoghi

• A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
  di: Bing Feng, et al.
  Pubblicazione: (2024)
• Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study
  di: Pulin Li, et al.
  Pubblicazione: (2024)
• Illuminating the genomic frontier of invasive non‐typhoidal Salmonella infections
  di: Hao Wang, et al.
  Pubblicazione: (2025)
• Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation
  di: Jie Huang, et al.
  Pubblicazione: (2024)
• Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy
  di: Li Li, et al.
  Pubblicazione: (2024)